Recombinant Human ANTXR2 Protein，His

ANTXR2, also known as anthrax toxin receptor 2, is a crucial protein that plays a significant role in cellular activities, particularly in the context of anthrax pathogenesis. It is a member of the tumor necrosis factor receptor superfamily and is implicated in various physiological processes such as cell proliferation, differentiation, and apoptosis. Research on ANTXR2 has gained interest due to its potential involvement in cancer biology, as its expression patterns can be associated with tumor progression and metastasis. Moreover, ANTXR2 serves as a receptor for anthrax toxin, specifically binding to protective antigen and facilitating the entry of lethal factors into host cells. This dual role makes it a target of interest for therapeutic interventions, as blocking this interaction could have implications for anthrax treatment and the development of novel cancer therapies. As such, studies focusing on the structure, function, and signaling pathways of ANTXR2 are essential to understanding its contributions to disease mechanisms. Ongoing research aims to elucidate its roles in various biological contexts, paving the way for potential biotechnological and clinical applications. Understanding ANTXR2 at the molecular level may provide insights into targeted therapies, improving treatment strategies for diseases associated with its dysregulation.